跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Telmisaph-40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Telmisaph-40
Approved
STANDARD
Telmisaph-40
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
35ba4a5f5e313d86
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
35ba4a5f5e313d86
Drug Approval Philippines Name
Telmisaph-40
Product Name
Telmisaph-40
Registration Number
DRP-9616
Brand Name
Telmisaph-40
Generic Name
Telmisartan
Dosage Form
Tablet
Dosage Strength
40 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
25 March 2021
Expiry Date
25 March 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
35ba4a5f5e313d86
Type
Standard
Back to Philippines FDA Approvals